Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug4788 | tracheostomy Wiki | 1.00 |
| drug4539 | intubation Wiki | 1.00 |
| drug3150 | Pulmonary function test Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D003141 | Communicable Diseases NIH | 0.07 |
| D007239 | Infection NIH | 0.05 |
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Massive number of clinicians were infected during the outbreak of COVID-19, which raised the concerns of utilizing "aerosol generating procedures", particularly the use of high-flow nasal cannula, noninvasive ventilation, intubation, bronchoscopy examination and pulmonary function test. There appears to be a trend to avoid those treatments. Instead, aggressive intubation might cause shortage of medical devices and add extra workload. Therefore, we aimed to do a clinical observational study to evaluate the aerosol generation in these procedures and explore the potential measures to reduce the aerosol generation or dispersion.
Description: The aerosol mass/count concentration pre procedure/treatment at 1 foot away from patient's airway in the patient's room
Measure: The aerosol mass/count concentration pre procedure/treatment at 1 foot away from patient Time: 5 minutes before procedure/treatmentDescription: The virus load in the air sample pre procedure/treatment at 1 foot away from patient's airway in the patient's room
Measure: The virus load in the air sample pre procedure/treatment at 1 foot away from patient Time: 1 hour before procedure/treatmentDescription: The virus load in the air sample during/after procedure/treatment at 1 foot away from patient's airway in the patient's room
Measure: The virus load in the air sample during/after procedure/treatment at 1 foot away from patient Time: 1 hour during/after procedure/treatmentDescription: The aerosol mass/count concentration pre procedure/treatment at 3 feet away from patient's airway in the patient's room
Measure: The aerosol mass/count concentration pre procedure/treatment at 3 feet away from patient Time: 5 minutes before procedure/treatmentDescription: The aerosol mass/count concentration and virus load in the air sample during procedure/treatment at 1 foot away from patient's airway in the patient's room
Measure: The aerosol mass/count concentration and virus load in the air sample during procedure/treatment at 1 foot away from patient Time: during procedure/treatmentDescription: The aerosol mass/count concentration during procedure/ treatment at 3 feet away from HFNC in the patient's room
Measure: The aerosol mass/count concentration during procedure/ treatment at 3 feet away from patient Time: during procedure/treatmentDescription: The aerosol mass/count concentration post procedure/ treatment at 1 foot away from HFNC in the patient's room
Measure: The aerosol mass/count concentration post procedure/ treatment at 1 foot away from patient Time: 5 minutes post procedure/treatmentDescription: The aerosol mass/count concentration 5 mins procedure/ treatment at 3 feet away from HFNC in the patient's room
Measure: The aerosol mass/count concentration 5 mins post procedure/ treatment at 3 feet away from patient Time: 5 minutes post procedure/treatmentAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports